Jade André de Souza
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jade André de Souza has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Alexandre M. Fuentefria
Postgraduate Program in Pharmaceutical Science, Faculty of Pharmacy, Universidade Federal do Rio Grande do Sul (UFRGS), Brazil; Postgraduate Program in Pharmacology and Therapeutics, Institute of Basic Health Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
1 shared publication - Alexandre Meneghello Fuentefria
Universidade Federal do Rio Grande do Sul
1 shared publication - Alícia da Costa Pereira
Faculty of Pharmacy, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
1 shared publication - Bárbara Rodrigues Daher1 shared publication
- Eduardo Luis Konrath
Postgraduate Program in Pharmaceutical Science, Faculty of Pharmacy, Universidade Federal do Rio Grande do Sul (UFRGS), Brazil
1 shared publication - Letícia F. G. Kinape
Postgraduate Program in Pharmacology and Therapeutics, Institute of Basic Health Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
1 shared publication
Latest Publications
- Open Access
- 5 July 2026
- Published by Elsevier in Journal of Medical Mycology
- Vol. 36 (3) , 101637
Alkaloid hyemaline exhibits novel in vitro and in vivo antidermatophytic activity
- 5 July 2026
- Published by Elsevier in Journal of Medical Mycology
- Vol. 36 (3) , 101637
Open AccessAlkaloid hyemaline exhibits novel in vitro and in vivo antidermatophytic activity
- 3 November 2025
- Published by Brazilian Journals in Brazilian Journal of Health Review
- Vol. 8 (6) , e84877
Detection of M1 aflatoxin in colonial cheeses marketed in southern Brazil
Aflatoxins are carcinogenic and toxic secondary metabolites produced by filamentous fungi. The dairy industry faces challenges with fungal contamination in cheese, which can lead to the presence of mycotoxins. This study aimed to evaluate the aflatoxin contamination in colonial cheeses produced by family agribusiness and marketed along highways in the Taquari Valley, in central region of Rio Grande do Sul, Brazil. Fifteen samples were analyzed using a competitive enzyme-linked immunosorbent assay (ELISA). The results demonstrated levels of aflatoxin M1 (AFM1) in these samples ranging from 0.04 to 0.56 µg/kg. Fourteen samples (93.3%) contained AFM1 levels above the maximum limit tolerated by the European Community (0.05 µg/kg). However, all samples were below the Brazilian regulatory limit (2.5 µg/kg). In view of this, the high frequency of detectable AFM1 raises public health concerns, as the safety of chronic exposure to these levels is not fully established. These findings emphasized the need for stricter quality control throughout the milk and cheese production chain to ensure product safety and protect consumer health in the long term.
- 3 November 2025
- Published by Brazilian Journals in Brazilian Journal of Health Review
- Vol. 8 (6) , e84877
Detection of M1 aflatoxin in colonial cheeses marketed in southern Brazil
Aflatoxins are carcinogenic and toxic secondary metabolites produced by filamentous fungi. The dairy industry faces challenges with fungal contamination in cheese, which can lead to the presence of mycotoxins. This study aimed to evaluate the aflatoxin contamination in colonial cheeses produced by family agribusiness and marketed along highways in the Taquari Valley, in central region of Rio Grande do Sul, Brazil. Fifteen samples were analyzed using a competitive enzyme-linked immunosorbent assay (ELISA). The results demonstrated levels of aflatoxin M1 (AFM1) in these samples ranging from 0.04 to 0.56 µg/kg. Fourteen samples (93.3%) contained AFM1 levels above the maximum limit tolerated by the European Community (0.05 µg/kg). However, all samples were below the Brazilian regulatory limit (2.5 µg/kg). In view of this, the high frequency of detectable AFM1 raises public health concerns, as the safety of chronic exposure to these levels is not fully established. These findings emphasized the need for stricter quality control throughout the milk and cheese production chain to ensure product safety and protect consumer health in the long term.